References

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

10.1200/jco.1999.17.3.776 · 1999 · External reference

Clinical presentation and treatment of lymphocyte predominant Hodgkin's disease

1999 · External reference

Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California

10.1158/1055-9965.epi-04-0567 · 2005 · External reference

Hodgkin's disease in Asians. Incidence patterns and risk factors in population-based data

10.1016/s0145-2126(01)00126-6 · 2002 · External reference

Geographic variation of Hodgkin's disease in Japan

1981 · External reference

The pathology and nomenclature of Hodgkin's disease

1966 · External reference

Staging for Hodgkin's disease

1990 · External reference

Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and pred-nisone)

1991 · External reference

Combined cyclophosphamide, vincristine, procarbazine, and pred-nisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients

10.1002/1097-0142(197510)36:4<1241::aid-cncr2820360409>3.0.co;2-5 · 1975 · External reference

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience

10.1093/annonc/2.suppl_1.9 · 1991 · External reference

Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

10.1007/bf02985239 · 1989 · External reference

BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkin's disease—results of the German Hodgkin Study Group

10.1080/10428190500178167 · 2005 · External reference

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

10.1056/nejm199811193392104 · 1998 · External reference

The epidemiology of Hodgkin's disease

1999 · External reference

Hodgkin's disease in Hong Kong Chinese

10.1002/hon.2900070602 · 1989 · External reference

Hodgkin's disease in the Philippines

1996 · External reference

The association between Epstein-Barr virus and Chinese Hodgkin's disease

10.1002/ijc.2910550303 · 1993 · External reference

Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey

10.1093/annonc/mdh132 · 2004 · External reference

Classical Hodgkin's lym-phoma

2001 · External reference

Non-Hodgkin's lymphomas in Asia

10.1016/s0889-8588(18)30396-4 · 1991 · External reference

Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma

10.1093/annonc/mdh263 · 2004 · External reference

Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells

10.1016/s1470-2045(03)01319-6 · 2004 · External reference

Part II. Hodgkin's lymphoma—diagnosis and treatment

10.1016/s1470-2045(03)01320-2 · 2004 · External reference

Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications

10.1200/jco.2005.02.9850 · 2006 · External reference

Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation

10.1200/jco.2006.05.6879 · 2006 · External reference

Salvage Therapy in Hodgkin's Lymphoma

10.1634/theoncologist.12-2-156 · 2007 · External reference

Stem cell transplantation in Hodgkin's lymphoma

10.1586/14737140.7.3.297 · 2007 · External reference

The role of allogeneic stem-cell transplantation in Hodgkin's disease

10.1111/j.1600-0609.2005.00469.x · 2005 · External reference

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin's lymphoma: results of a Spanish prospective cooperative protocol

10.1016/j.bbmt.2005.09.009 · 2006 · External reference

Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: where do we stand?

10.1016/j.bbmt.2006.03.013 · 2006 · External reference

Myocardial infarction mortality risk after treatment for Hodgkin's disease: a collaborative British cohort study

10.1093/jnci/djk029 · 2007 · External reference

Hodgkin's disease: prognostic factors and treatment strategies

10.1097/00001622-200009000-00004 · 2000 · External reference